SNCG (Breast Cancer-Specific Protein 1) antibody
-
- Target
- SNCG (Breast Cancer-Specific Protein 1)
- Reactivity
- Human
- Host
- Please inquire
-
Clonality
- Monoclonal
-
Conjugate
- Un-conjugated
- Application
- Immunohistochemistry (IHC), ELISA, Western Blotting (WB)
- Specificity
- Ni-NTA purified truncated recombinant SNCG expressed in E. Coli strain BL21 (DE3)
- Purification
- Antibodies are purified by protein A affinity chromatography
- Isotype
- IgG1
-
-
- Application Notes
-
Western Blot: 1: 500- 1: 2,000
IHC(P): 1: 500- 1: 2,000
IHC(F): 1: 500- 1: 2,000
ELISA: Propose dilution 1: 10,000.
Determining optimal working dilutions by titration test. - Restrictions
- For Research Use only
-
- Storage
- -20 °C
-
-
gamma-synuclein has a dynamic intracellular localization." in: Cell motility and the cytoskeleton, Vol. 63, Issue 8, pp. 447-58, (2006) (PubMed).
: "
-
gamma-synuclein has a dynamic intracellular localization." in: Cell motility and the cytoskeleton, Vol. 63, Issue 8, pp. 447-58, (2006) (PubMed).
-
- Target
- SNCG (Breast Cancer-Specific Protein 1)
- Background
- SNCG(also designated gamma-synuclein or breast cancer-specific protein 1),with 127-amino acid protein(about 14kDa), belongs to the synuclein family, which also includes alpha- and beta- synuclein. Three synucleins are located in the neuronal cytosol and enriched in presynaptic terminals,while SNCG is also expressed in many other non-neuronal tissues. SNCG is abnormally expressed in a high percentage of tumor tissues of diversified cancer types, including liver, esophagus, colon, gastric, lung, prostate, cervical, and breast cancer, but rarely expressed in tumor-matched nonneoplastic adjacent tissues. High levels of SNCG have been identified in advanced breast carcinomas suggesting a correlation between overexpression of SNCG and breast tumor development.
- Gene ID
- 6623
-